Correction of Diabetic Erectile Dysfunction with Adipose Derived Stem Cells Modified with the Vascular Endothelial Growth Factor Gene in a Rodent Diabetic Model

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Liu, Guihua ^a,b   Sun, Xiangzhou ^a   Bian, Jun ^c   Wu, Rongpei ^a,b   Guan, Xuan ^b   Ouyang, Bin ^a   Huang, Yanping ^a   Xiao, Haipeng ^a   Luo, Daosheng ^d   Atala, Anthony ^b   Zhang, Yuanyuan ^b   Deng, Chunhua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^d DONGGUAN PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; APOMORPHINE; BIOLOGICAL MARKER; CD146 ANTIGEN; CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHATE BUFFERED SALINE; PROTEIN NG2; SMOOTHELIN; STREPTOZOCIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CORPUS CAVERNOSUM; DIABETES MELLITUS; DIABETIC ERECTILE DYSFUNCTION; ENDOTHELIUM CELL; ERECTILE DYSFUNCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LENTIVIRINAE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERICYTE; PRESSURE MEASUREMENT; RAT; RODENT MODEL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; CELLS, CULTURED; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ERECTILE DYSFUNCTION; GENETIC THERAPY; HUMANS; MALE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE III; PERICYTES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; STEM CELL TRANSPLANTATION; STEM CELLS; STREPTOZOCIN; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84883384047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072790     Document Type: Article

References (42)

1. Malavige LS, Levy JC, (2009) Erectile dysfunction in diabetes mellitus. J Sex Med 6: 1232-1247.
2. Thorve VS, Kshirsagar AD, Vyawahare NS, Joshi VS, Ingale KG, et al. (2011) Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications 25: 129-136.
3. Saenz de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, et al. (2005) Pathophysiology of erectile dysfunction. J Sex Med 2: 26-39.
4. Huang Y, Sun X, Liu G, Yao F, Zheng F, et al. (2011) Glycosylated serum protein may improve our ability to predict endothelial and erectile dysfunction in nonorganic patients. J Sex Med 8: 840-850.
5. Liu G, Sun X, Dai Y, Zheng F, Wang D, et al. (2010) Chronic administration of sildenafil modified the impaired VEGF system and improved the erectile function in rats with diabetic erectile dysfunction. J Sex Med 7: 3868-3878.
6. Jesmin S, Sakuma I, Salah-Eldin A, Nonomura K, Hattori Y, et al. (2003) Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction in diabetes. J Mol Endocrinol 31: 401-418.
7. Long T, Liu G, Wang Y, Chen Y, Zhang Y, et al. (2012) TNF-alpha, erectile dysfunction, and NADPH oxidase-mediated ROS generation in corpus cavernosum in high-fat diet/streptozotocin-induced diabetic rats. J Sex Med 9: 1801-1814.
8. Stuckey BG, Jadzinsky MN, Murphy LJ, Montorsi F, Kadioglu A, et al. (2003) Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 26: 279-284.
9. Kolluru GK, Bir SC, Kevil CG, (2012) Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012: 918267.
10. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, et al. (2008) Recent advances in andrology-related stem cell research. Asian J Androl 10: 171-175.
11. Janeczek Portalska K, Leferink A, Groen N, Fernandes H, Moroni L, et al. (2012) Endothelial differentiation of mesenchymal stromal cells. PLoS One 7: e46842.
12. Lee RH, Oh JY, Choi H, Bazhanov N, (2011) Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem 112: 3073-3078.
13. Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, et al. (2012) Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 7: e47559.
14. Qiu X, Lin H, Wang Y, Yu W, Chen Y, et al. (2011) Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocin-induced diabetic rats. J Sex Med 8: 427-436.
15. Lin CS, Xin ZC, Wang Z, Deng C, Huang YC, et al. (2012) Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev 21: 343-351.
16. Morizono K, De Ugarte DA, Zhu M, Zuk P, Elbarbary A, et al. (2003) Multilineage cells from adipose tissue as gene delivery vehicles. Hum Gene Ther 14: 59-66.
17. Garcia MM, Fandel TM, Lin G, Shindel AW, Banie L, et al. (2010) Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med 7: 89-98.
18. Pons J, Huang Y, Arakawa-Hoyt J, Washko D, Takagawa J, et al. (2008) VEGF improves survival of mesenchymal stem cells in infarcted hearts. Biochem Biophys Res Commun 376: 419-422.
19. Liu S, Zhang H, Zhang X, Lu W, Huang X, et al. (2011) Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair. Tissue Eng Part A 17: 725-739.
20. Sun XZ, Liu GH, Wang ZQ, Zheng FF, Bian J, et al. (2011) Over-expression of VEGF165 in the adipose tissue-derived stem cells via the lentiviral vector. Chin Med J (Engl) 124: 3093-3097.
21. Heaton JP, Varrin SJ, Morales A, (1991) The characterization of a bio-assay of erectile function in a rat model. J Urol 145: 1099-1102.
22. Giuliano F, Bernabe J, Jardin A, Rousseau JP, (1993) Antierectile role of the sympathetic nervous system in rats. J Urol 150: 519-524.
23. De Young LX, Domes T, Lim K, Carson J, Brock GB, (2008) Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats. Eur Urol 54: 213-220.
24. Sheetz MJ, King GL, (2002) Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288: 2579-2588.
25. Prakash R, Somanath PR, El-Remessy AB, Kelly-Cobbs A, Stern JE, et al. (2012) Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes 61: 1533-1542.
26. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, et al. (2002) Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105: 373-379.
27. Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, et al. (2005) Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes 54: 3435-3441.
28. Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, et al. (2005) Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes 54: 785-794.
29. Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M, (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16: 94-112.
30. Li WJ, Zhou J, Li B, Wang H, Peng YB, et al. (2011) PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats. J Sex Med 8: 1072-1082.
31. Wespes E, (2002) Smooth muscle pathology and erectile dysfunction. Int J Impot Res 14Suppl 1: S17-21.
32. Bergers G, Song S, (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452-464.
33. Bouacida A, Rosset P, Trichet V, Guilloton F, Espagnolle N, et al. (2012) Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells. PLoS One 7: e48648.
34. Hall AP, (2006) Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol Pathol 34: 763-775.
35. Fakhrejahani E, Toi M, (2012) Tumor angiogenesis: pericytes and maturation are not to be ignored. J Oncol 2012: 261750.
36. Armulik A, Abramsson A, Betsholtz C, (2005) Endothelial/pericyte interactions. Circ Res 97: 512-523.
37. Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, et al. (2001) Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15: 1239-1241.
38. Fandel TM, Albersen M, Lin G, Qiu X, Ning H, et al. (2012) Recruitment of intracavernously injected adipose-derived stem cells to the major pelvic ganglion improves erectile function in a rat model of cavernous nerve injury. Eur Urol 61: 201-210.
39. Zhang H, Ning H, Banie L, Wang G, Lin G, et al. (2010) Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties. Biochem Biophys Res Commun 402: 560-564.
40. Das H, George JC, Joseph M, Das M, Abdulhameed N, et al. (2009) Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One 4: e7325.
41. Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, et al. (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10: 590-594.
42. Ribatti D, Vacca A, Presta M, (2000) The discovery of angiogenic factors: a historical review. Gen Pharmacol 35: 227-231.